EcoDrugPlus

Aurora Kinase A

Ensembl ID : ENSEBUG00000000367
Gene Symbol: AURKA
1 Cross references
235 Possible Orthologues:

Beta-Secretase 1

Ensembl ID : ENSEBUG00000008098
Gene Symbol: BACE1
1 Cross references
221 Possible Orthologues:

Calcium Channel, Voltage-Dependent, Gamma Subunit 1a

Ensembl ID : ENSEBUG00000009101
Gene Symbol: CACNG1A
1 Cross references
515 Possible Orthologues:

Calcium Channel, Voltage-Dependent, Gamma Subunit 5a

Ensembl ID : ENSEBUG00000014641
Gene Symbol: CACNG5A
1 Cross references
252 Possible Orthologues:

Calcium Sensing Receptor

Ensembl ID : ENSEBUG00000000474
Gene Symbol: CASR
1 Cross references
203 Possible Orthologues:

Cathepsin C

Ensembl ID : ENSEBUG00000003805
Gene Symbol: CTSC
1 Cross references
237 Possible Orthologues:

Cholecystokinin B Receptor A

Ensembl ID : ENSEBUG00000005124
Gene Symbol: CCKBRA
1 Cross references
270 Possible Orthologues:

Cholinergic Receptor Muscarinic 3

Ensembl ID : ENSEBUG00000002141
Gene Symbol: CHRM3
1 Cross references
258 Possible Orthologues:

Cholinergic Receptor Nicotinic Alpha 3 Subunit

Ensembl ID : ENSEBUG00000004381
Gene Symbol: CHRNA3
1 Cross references
207 Possible Orthologues:

Cholinergic Receptor Nicotinic Beta 4 Subunit

Ensembl ID : ENSEBUG00000010110
Gene Symbol: CHRNB4
1 Cross references
274 Possible Orthologues:

Cholinergic Receptor, Nicotinic, Alpha 4b

Ensembl ID : ENSEBUG00000014503
Gene Symbol: CHRNA4B
1 Cross references
206 Possible Orthologues:

Coagulation Factor Ii (Thrombin) Receptor-Like 1, Tandem Duplicate 1

Ensembl ID : ENSEBUG00000002281
Gene Symbol: F2RL1.1
1 Cross references
1113 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).